International Care Bundle Evaluation in Cerebral Hemorrhage Research

Recruiting Phase 4 Interventional Study
Intracerebral Hemorrhage Intracerebral Haemorrhage Intraventricular Hemorrhage Stroke Cerebrovascular Disease
Prior Safety Data This treatment has already been tested in at least one earlier human trial.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Trial phase
Phase 4
Study type
Interventional
Purpose
Treatment
Participants needed
3,500 (estimated)
Sponsor
Region Skane · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Spontaneous intracerebral haemorrhage (ICH) accounts for approximately 10-15% of all strokes but stands for 50% of stroke-related morbidity and mortality. Approximately half of all patients with ICH have a decreased level of consciousness at hospital admission. Despite this, intensive care and neurosurgical interventions are uncommon. A study conducted in low- and middle-income countries has demon…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Adults (age ≥18 years) * Non-contrast computerized tomography (NCCT) imaging-verified diagnosis of spontaneous intracerebral haemorrhage * ≤24 hours from symptom onset or presumed symptom onset (last seen well) Exclusion Criteria: * Previous care limitation * End-stage comor…
Contacts

Teresa Ullberg, MD, PhD

0046175057

i-catcher@med.lu.se

CONTACT

Trine Apostolaki-Hansson, MD PhD

trine.apostolaki-hansson@med.lu.se

CONTACT